Organon Analyst Price Targets - Benzinga

Organon & Co

OGNNYSE

Trade with Public

Trade with Public

$13.77

0.0150.11%

Últ. Act.: Oct 20, 12:19 PM

$13.74

-0.01-0.07%

Panorámica general Noticias Previsión de beneficios EventosPrecios objetivoFinanzas Sentimiento Propiedad Dividendos Comparar Opciones Informe de acciones

© 2026 Benzinga | All Rights Reserved

Organon Analyst Price Targets

Wall Street analyst price targets and consensus rating for Organon (OGN).

Price Target Range — 9 Quarters

Analyst Consensus — 5 Analysts

3Hold

2Sell

Consensus RatingNeutral# Analysts5Avg. Consensus PT$14Upside to Avg. PT+4.8%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Apr 29, 2026	BNP Paribas	Navann Ty	Downgrade	Outperform→Neutral	$12→$14
Apr 28, 2026	Piper Sandler	David Amsellem	Upgrade	Underweight→Neutral	$5→$14
Feb 24, 2026	Barclays	Glen Santangelo	PT Raise	Underweight	$8→$8
Dec 9, 2025	Barclays	Glen Santangelo	Initiate	Underweight	$8
Nov 11, 2025	JP Morgan	Chris Schott	PT Cut	Underweight	$14→$12
Nov 11, 2025	Morgan Stanley	Terence Flynn	PT Cut	Equal-Weight	$10→$9
May 15, 2025	Piper Sandler	David Amsellem	PT Cut	Overweight	$24→$18
May 5, 2025	Morgan Stanley	Terence Flynn	PT Cut	Equal-Weight	$15→$10
Apr 9, 2025	Morgan Stanley	Terence Flynn	PT Cut	Equal-Weight	$16→$15
Feb 14, 2025	Barclays	Balaji Prasad	PT Cut	Overweight	$26→$24
Feb 14, 2025	Morgan Stanley	Terence Flynn	PT Cut	Equal-Weight	$17→$16
Sep 6, 2024	JP Morgan	Chris Schott	Downgrade	Neutral→Underweight	$18→$20
May 6, 2024	Goldman Sachs	Chris Shibutani	PT Raise	Neutral	$18→$20
May 3, 2024	Goldman Sachs	Chris Shibutani	PT Raise	Neutral	$18→$20
Apr 29, 2024	Piper Sandler	David Amsellem	PT Raise	Overweight	$22→$24
Feb 20, 2024	Goldman Sachs	Chris Shibutani	PT Raise	Neutral	$16→$18
Nov 22, 2023	Piper Sandler	David Amsellem	PT Cut	Overweight	$32→$22
Nov 3, 2023	Goldman Sachs	Chris Shibutani	Downgrade	Buy→Neutral	$33→$16
Oct 25, 2023	Piper Sandler	David Amsellem	PT Cut	Overweight	$33→$32

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
BNP Paribas Downgrades Organon to Neutral, Raises Price Target to $14

BNP Paribas analyst Navann Ty downgrades Organon (NYSE:OGN) from Outperform to Neutral and raises the price target from $12 to $14.

Benzinga Newsdesk

This Old Dominion Freight Line Analyst Is No Longer Bearish; Here Are Top 3 Upgrades For Tuesday

Analysts upgraded ODFL, TFII, OGN with positive outlook. See analyst ratings and stock performance.

Avi Kapoor

PRO
Piper Sandler Upgrades Organon to Neutral, Raises Price Target to $14

Piper Sandler analyst David Amsellem upgrades Organon (NYSE:OGN) from Underweight to Neutral and raises the price target from $5 to $14.

Benzinga Newsdesk

PRO
Barclays Maintains Underweight on Organon, Raises Price Target to $8

Barclays analyst Glen Santangelo maintains Organon (NYSE:OGN) with a Underweight and raises the price target from $7.5 to $8.

Benzinga Newsdesk

PRO
Barclays Initiates Coverage On Organon with Underweight Rating, Announces Price Target of $7.5

Barclays analyst Glen Santangelo initiates coverage on Organon (NYSE:OGN) with a Underweight rating and announces Price Target of $7.5.

Benzinga Newsdesk

Organon Analysts Cut Their Forecasts Following Q3 Results

Avi Kapoor